DCAF7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.748750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.160600E-01
Normal-vs-Stage2
1.830420E-01
Normal-vs-Stage3
4.493600E-02
Normal-vs-Stage4
6.586300E-02
Stage1-vs-Stage2
8.309000E-01
Stage1-vs-Stage3
3.242800E-01
Stage1-vs-Stage4
7.133400E-01
Stage2-vs-Stage3
2.023000E-01
Stage2-vs-Stage4
8.746200E-01
Stage3-vs-Stage4
1.925410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.253800E-02
Normal-vs-AfricanAmerican
6.220800E-01
Normal-vs-Asian
2.811800E-01
Caucasian-vs-AfricanAmerican
2.258600E-01
Caucasian-vs-Asian
6.770000E-01
AfricanAmerican-vs-Asian
2.735400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.914500E-02
Normal-vs-Female
3.424400E-01
Male-vs-Female
6.516300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.221380E-01
Normal-vs-Age(41-60Yrs)
3.738200E-01
Normal-vs-Age(61-80Yrs)
1.311980E-01
Normal-vs-Age(81-100Yrs)
2.425700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.401600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.212000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.941200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.243600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.234000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.789800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.618100E-02
Normal-vs-Daily Drinker
3.290100E-02
Normal-vs-Weekly Drinker
6.405700E-02
Normal-vs-Occasional Drinker
2.586200E-01
Normal-vs-Social Drinker
3.219000E-01
Non Drinker-vs-Daily Drinker
7.392600E-01
Non Drinker-vs-Weekly Drinker
9.028600E-01
Non Drinker-vs-Occasional Drinker
1.564960E-01
Non Drinker-vs-Social Drinker
6.647500E-02
Daily Drinker-vs-Weekly Drinker
6.702200E-01
Daily Drinker-vs-Occasional Drinker
8.263700E-02
Daily Drinker-vs-Social Drinker
2.809900E-02
Weekly Drinker-vs-Occasional Drinker
2.468400E-01
Weekly Drinker-vs-Social Drinker
1.065600E-01
Occasional Drinker-vs-Social Drinker
6.493200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.735620E-01
Normal-vs-Grade 2
1.612200E-01
Normal-vs-Grade 3
6.582200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.755400E-01
Grade 1-vs-Grade 3
8.131000E-01
Grade 1-vs-Grade 4
1.735620E-01
Grade 2-vs-Grade 3
3.126400E-01
Grade 2-vs-Grade 4
1.612200E-01
Grade 3-vs-Grade 4
6.582200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.017500E-02
Normal-vs-NonDiabetic
2.343400E-01
Diabetic-vs-NonDiabetic
3.742400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.357050E-01
Normal-vs-NoPancreatitis
1.687410E-01
Pancreatitis-vs-NoPancreatitis
9.794200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.541200E-01
Normal-vs-N1
1.073380E-01
N0-vs-N1
5.330600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.285630E-01
Normal-vs-TP53-NonMutant
3.566400E-01
TP53-Mutant-vs-TP53-NonMutant
5.798800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
